Abstract:OBJECTIVE:To evaluate the value of fusion imaging with post-treatment contrast-enhanced ultrasound (CEUS) and pre-treatment contrast-enhanced CT/MRI (CECT/CEMRI) in evaluating ablative safety margin after percutaneous ultrasound (US)-guided radiofrequency ablation (RFA) for liver cancers.METHODS:34 consecutive patients with 47 liver lesions who had undergone RFA were included. Fusion imaging with post-treatment CEUS and pre-treatment CECT/CEMRI was carried out to evaluate local treatment response and ablative safety margin within 1-3 days after RFA. The minimal ablative safety margins of the ablation zones were recorded. The complete response (CR) rate was calculated with reference to CECT/CEMRI results 1 month after RFA. The local tumour progression (LTP) was also recorded.RESULTS:Of the 47 ablation zones, 47 (100%) were clearly depicted with CEUS-CECT/CEMRI fusion imaging, 36 (76.6%) with US-CECT/CEMRI fusion imaging and 21 (44.7%) with conventional US (both p < 0.001). The minimal ablative safety margins were great than or equal to 5 mm in 28 ablation zones, between 0 and 5 mm in 15, and less than 0 mm in 4. For the four lesions without enough ablative safety margin, three were referred to follow-up because CEUS showed larger ablation zones than pre-treatment lesions and the remaining lesion was subject to additional RFA 5 days after the first RFA. The CR rate was 95.7% (45/47) with reference to CECT/CEMRI results 1 month after RFA. During 2 to 34 months follow-up, LTP was found in two (4.4%) of 45 lesions with CR. Insufficient ablative safety margin was more commonly found in those lesions with LTP than those without LTP (1/4 vs 1/43, p < 0.001).CONCLUSION:Fusion imaging with post-treatment CEUS and pre-treatment CECT/CEMRI can depict the ablative safety margin accurately after RFA. Inadequate ablative safety margin is associated with LTP. Depiction of ablative safety margin by fusion imaging after ablation might be considered as a routine procedure to assess the treatment response of RFA. Advances in knowledge: Fusion imaging with post-treatment CEUS and pre-treatment CECT/CEMRI is an effective method to evaluate the ablative safety margin early after RFA. Therefore, it should be recommended to be used as a routine procedure after RFA for liver cancers.

3-D Contrast-Enhanced Ultrasound Fusion Imaging: A New Technique to Evaluate the Ablative Margin of Radiofrequency Ablation for Hepatocellular Carcinoma

A Feasibility Study for Determining Ablative Margin with 3D-CEUS-CT/MR Image Fusion after Radiofrequency Ablation of Hepatocellular Carcinoma.

Fusion Imaging of Contrast-Enhanced Ultrasound and Contrast-Enhanced CT or MRI Before Radiofrequency Ablation for Liver Cancers

Ablative Safety Margin Depicted by Fusion Imaging with Post-Treatment Contrast-Enhanced Ultrasound and Pre-Treatment CECT/CEMRI after Radiofrequency Ablation for Liver Cancers.

Assessment of Radiofrequency Ablation Margin by MRI-MRI Image Fusion in Hepatocellular Carcinoma

Dynamic Three-Dimensional Contrast-Enhanced Ultrasound to Predict Therapeutic Response of Radiofrequency Ablation in Hepatocellular Carcinoma: Preliminary Findings

Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients

Fusion Imaging Techniques and Contrast-Enhanced Ultrasound for Thermal Ablation of Hepatocellular Carcinoma – A Prospective Randomized Controlled Trial

Early Assessment of the Therapeutic Response to Radiofrequency Ablation for Hepatic Local Lesion with 3-Dimensional Contrast-Enhanced Ultrasound Registration System a Preliminary Study

Fusion Imaging-Guided Radiofrequency Ablation for Residual Hepatocellular Carcinoma Invisible on Ultrasound after Transcatheter Arterial Chemoembolization.

A Feasibility Study for Determining Ablative Margin with 3D-CEUS-CT/MR Image Fusion after Radio- frequency Ablation of Hepatocellular Carcinoma Durchführbarkeitsstudie zur Bestimmung des Ablationsrandes mittels 3D-CEUS- CT/MR-Bildfusion nach Radiofrequenzablation des hepatozellulären Karzinoms

Immediate Evaluation and Guidance of Liver Cancer Thermal Ablation by Three-Dimensional Ultrasound/contrast-Enhanced Ultrasound Fusion Imaging

Evaluation of Hepatocellular Carcinoma Ablation Using Image Fusion Assisted Contrast-Enhanced Ultrasound

Contrast-enhanced Ultrasound in the Characterization of Hepatocellular Carcinomas Treated by Ablation: Comparison with Contrast-Enhanced Magnetic Resonance Imaging.

Evaluation of hepatocellular carcinoma ablative margin using three-dimensional ultrasound-CT image fusion in a phantom study

Bipolar Radiofrequency Ablation for Liver Tumors: Comparison of Contrast-Enhanced Ultrasound with Contrast-Enhanced MRI/CT in the Posttreatment Imaging Evaluation.

Radiofrequency Ablation for Hepatocellular Carcinoma: Utility of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Guiding and Assessing Early Therapeutic Response and Short-Term Follow-Up Results

Clinical Value Of Combined Contrast-Enhanced Ultrasound And Elasticity Imaging In Evaluation Of Efficacy Of Radiofrequency Ablation For Hepatocellular Carcinoma

Intra-procedural CT/MR-CEUS Fusion Imaging Improved Thermal Ablation Effect of Hepatocellular Carcinoma: Compared with Conventional Ultrasound.

Study on Contrast-enhanced Ultrasound in the Assessment of Local Response to Ablation Therapy for Hepatocellular Carcinoma

Intraprocedural Contrast-Enhanced Ultrasound-Ct/mr Fusion Imaging Assessment in HCC Thermal Ablation to Reduce Local Tumor Progression: Compared with Routine Contrast-Enhanced Ultrasound